KLK10 was identified as a putative tumour suppressor in breast [34] and gastric cancers [35], and is often silenced in ovarian cancer cell lines and tumours [36], despite its expression in the serum being an unfavorable prognostic marker. This evidence concerns the gene KLK10 and ovarian cancer.